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Abstract
In order to evaluate the function of the retina in Best macular dystrophy (BMD) 18 patients were examined by means of the
multifocal electroretinogram (mfERG). The mfERG peak amplitudes of the central and pericentral responses were signiﬁcantly
reduced in the BMD patients (p < 0:001). The ERG amplitude decrease of the central response was signiﬁcantly correlated with
visual acuity loss and with the funduscopic staging. The implicit times in more eccentric groups were slightly but signiﬁcantly in-
creased. The markedly reduced mfERG amplitudes with only slightly increased implicit times may indicate cone photoreceptor cell
loss or damage to the cone outer segments.  2002 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Best macular dystrophy (BMD) represents an inher-
ited autosomal dominant, pleomorphic retinal disease.
It often occurs at a juvenile age, although genetic studies
on VMD2 mutations have revealed that BMD can de-
velop later, with an onset of visual failure around the
age of 40–50 years (Eksandh, Bakall, Bauer, Wadelius,
& Andreasson, 2001). BMD is associated with progres-
sive macular degeneration which may lead to a severe
loss of visual acuity. Typical ‘egg-yolk’ macular lesions
are seen funduscopically.
The pathomechanisms which are involved in BMD
are not yet clear. Several mutations of the VMD2 gene,
responsible for BMD, have been reported (Lotery et al.,
2000; Marquardt et al., 1998; Petrukhin et al., 1998).
Consistent with the disease phenotype, the VMD2
mRNA is heavily expressed in the retina, especially in
the retinal pigment epithelium (RPE) cells (Petrukhin
et al., 1998). The mutation results in an alteration of a
protein (bestrophin), which is probably membrane-
bound, with four putative transmembrane regions
(Bakall et al., 1999). Morphological studies have re-
vealed abnormalities including accumulated material
within the RPE (O’Gorman, Flaherty, Fishman, &
Berson, 1988; Weingeist, Kobrin, & Watzke, 1982) and
within photoreceptors (Frangieh, Green, & Fine, 1982).
It is still a matter of debate if the functional conse-
quences within the neurosensory retina result primarily
from the bestrophin mutations within photoreceptors or
secondarily from alterations within the RPE.
The notion that the primary defect is located within
the RPE is supported by the ﬁnding that the electro-
oculogram (EOG) is markedly abnormal in BMD. In
contrast, the a-wave and b-wave of the Ganzfeld elect-
roretinogram (ERG) are reported to be normal in BMD
(Denden, 1966; Deutmann, 1971; Francois, 1968; Krill,
1977; Krill, Morse, Potts, & Klien, 1966). A severely
abnormal EOG with a largely normal standard ERG is
thought to be characteristic of BMD (Fishman et al.,
1993). However, when large-ﬁeld L- and M-cone driven
ERGs are separately recorded (Kremers, Usui, Scholl, &
Sharpe, 1999; Scholl & Kremers, 2000), it was recently
found that the L- and M-cone driven ERGs were
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diﬀerently altered and that the mean maximal L/M-cone
driven ERG sensitivity was even increased in BMD
patients (Scholl, Kremers, Apfelstedt-Sylla, & Zrenner,
2000).
Clinical observations suggest that the retinal in-
volvement in BMD is not homogeneous so that topo-
graphical restrictedmeasurements are required. To detect
functional disturbances of the macula objectively, Fal-
sini et al. measured macular ﬂicker ERGs in BMD. They
found reduced amplitudes, indicating that the retina of
the posterior pole is involved in the early development of
BMD (Falsini et al., 1996). They did not make quanti-
tative comparisons of their results to psychophysical
data (such as the visual acuity), morphological data
(such as the fundus appearance), or disease history (such
as the disease duration).
The above-mentioned ERG methods have a limited
topographical resolution. The multifocal ERG (mfERG)
on the other hand, allows simultaneous recording of
many local ERGs from the posterior pole and thus
provides spatial information not readily available in the
Ganzfeld, large-ﬁeld, or macular ﬂicker ERG. The ﬁrst-
order kernel responses show close correlation with the
photopic Ganzfeld ERG (Hood, 2000; Hood, Seiple,
Holopigian, & Greenstein, 1997) and with the cone
density distribution found by histological methods
(Curcio, Sloan, Kalina, & Hendrickson, 1990). We re-
corded mfERGs from patients with BMD and corre-
lated measures of the mfERG ﬁrst-order kernel
responses to visual acuity, fundus staging, age of onset,
and disease duration.
2. Subjects and methods
2.1. Subjects
Eighteen eyes of 18 patients with BMD were involved
in the study. The diagnosis of BMD was based on his-
tory (including a detailed family history), visual ﬁelds
(30 T€ubingen Automated Perimetry), symmetrical bi-
lateral involvement, and the typical alterations of the
RPE assessed by retinal biomicroscopy and fundus
photography and a considerably reduced light-peak to
dark-trough ratio of the EOG slow oscillations (L/D
ratio). The age of onset of BMD was based on the his-
tory for the ﬁrst report of a loss in visual acuity. Fundus
photographs were staged according to the classiﬁcation
of Fishman et al. (1993), from a normal fovea with an
abnormal EOG (stage 0), over a minimal macular pig-
ment mottling and hypopigmentation (stage I), a typical
egg-yolk vitelliform lesion (stage II), various stages of
resorption of the vitelliform lesion (stage III), to re-
sorption plus ﬁbrotic- or gliotic-appearing scar forma-
tion either with or without a neovascular membrane
(stage IV). One patient (#4) was screened for mutations
in the VMD2 gene and was found to have an Arg25Trp
sequence change in exon 2, which is considered to be a
probable and possible disease-causing mutation in the
VMD2 gene (Lotery et al., 2000). Fifty-ﬁve eyes of 55
normal subjects served as controls.
Informed consent was obtained from all subjects after
explanation of the purpose and possible consequences of
the study. The study was conducted in accordance with
the tenets of the Declaration of Helsinki.
2.2. Stimulation
The stimulus, consisting of 61 hexagons covering a
visual ﬁeld of 30, was presented on a monitor with a
frame rate of 75 Hz at a distance of 28 cm from the
subject’s eye. The radius of the central hexagonal ele-
ment was 2. The hexagons were scaled with eccentric-
ity, the most eccentric being 4.7 times larger than the
central one (Fig. 1). Each element alternated between
black and white (93% contrast, mean luminance 51.8 cd/
m2) according to a binary m-sequence. During 3.63 min
of recording, 16383 diﬀerent stimulus permutations were
presented. A red central ﬁxation point of 2 mm diameter
was used.
2.3. Electrophysiological recordings
The pupils were dilated with 0.5% tropicamide and
5% phenylephrine and the refractive errors corrected.
The eyes were kept light-adapted for at least 10 min
Fig. 1. Geometry of the test ﬁeld containing 61 stimulated areas. For
further analysis these areas were grouped into ﬁve concentric rings
(1–5). There is an overlap of eccentricity in each group: ring 1 (0–2);
ring 2 (1.8–7), ring 3 (5–13); ring 4 (11–22); ring 5 (17–30.5). The
stimulus is superimposed onto the fundus photograph of a BMD pa-
tient (#4; carrying a disease-causing mutation in the VMD2 gene) to
help visualize the topography of the stimulus on the retina.
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prior to the ERG recording. Corneal ERG responses
were measured with DTL ﬁber electrodes which were
positioned on the conjunctiva directly beneath the cor-
nea and attached with the two ends at the lateral and
nasal canthus. The reference and skin electrodes (gold
cup electrodes) were attached to the ipsilateral temple
and the forehead, respectively. The signals were ampli-
ﬁed (200 000) and bandpass-ﬁltered (10–100 Hz; Grass
ampliﬁer, model 12; Quincy, USA). Each recording
session was subdivided into 20 recording segments of
approximately 11 s duration. The total duration of a
recording session was about 5–7 min.
2.4. Data analysis
The VERIS Scientiﬁc softwaree, using a fast m-
transform algorithm, was employed for the calculation
of the 61 local ERG responses from the measured signal
(Sutter, 1991, 1992). Speciﬁcally, ﬁrst-order kernels were
used in this study because of their close correlation with
the function of the outer retina (Hood et al., 1997). The
resulting 61 ERG traces are shown in the form of a trace
array for a normal subject in Fig. 2A. Due to the scaling
of the stimulus (the area of the hexagons increases to-
wards the periphery to compensate for lower cone
density), the resulting 61 local ERG responses are al-
most equal in amplitude for the normal observer (Fig.
2A). To reduce the complexity of 61 ERG responses,
ﬁve regional groups were formed by averaging responses
from elements of equal eccentricity (Fig. 1) (Sutter &
Tran, 1992). In Fig. 2B, the ERG responses for rings 1–5
are shown for a normal subject. The responses are
density scaled. The response density is obtained by di-
viding local ERGs by the area they were elicited from. A
typical wave form begins with a negative deﬂection
(N1), followed by a positive deﬂection (P1), and a sec-
ond negative deﬂection (N2). For the analysis of the
ERG amplitude data, we calculated the peak amplitude,
which is the diﬀerence between N1 and P1. For the
analysis of the ERG temporal data, we restricted the
analysis to the implicit time of the positive deﬂection
(P1). Additionally, three-dimensional plots of the re-
sponse density using the scalar product method (Sutter
& Tran, 1992) are shown in Fig. 2C.
2.5. Standard EOG and photopic Ganzfeld ERG
An EOG was obtained according to the ISCEV
standard (Marmor & Zrenner, 1993) and served as a
criterion for the diagnosis of BMD. All BMD patients
exhibited considerably reduced L/D ratios (range: 1.0–
1.85; mean: 1.4; standard deviation (S.D.): 0.3; 90%
conﬁdence interval of the normal subjects: 2.1–3.0).
Additionally, in a subset of 15 patients, a photopic
Ganzfeld ERG was obtained according to the ISCEV
standard (Marmor & Zrenner, 1998).
2.6. Statistical analysis
Data were analyzed by JMP 3.2.6 computer pro-
gram (SAS Institute, Inc., Cary, NC, USA). Results
with p-values < 0:05 were considered statistically sig-
niﬁcant. The ERG amplitudes and implicit times of the
BMD patients and the normal subjects were compared
by an analysis of covariance (ANCOVA) in order to




The age of the BMD patients (range: 7–55 years;
median: 37.5 years) did not diﬀer signiﬁcantly (p ¼ 0:16,
unpaired t-test) from that of the normal subjects (range:
12–67 years; median: 37 years). Subject groups did not
diﬀer in their proportion of male to female subjects
(p ¼ 0:59, two-tailed Fisher’s exact test). In nine patients
(#4, #7–9, #11–15), there was an obvious dominant
family history with aﬀected members in at least three
consecutive generations. In the other nine patients,
dominant inheritance was not evident. These patients
were considered as simplex cases. The clinical data of the
BMD patients together with photopic ERG b-wave
amplitudes and implicit times are shown in Table 1.
3.2. Amplitudes of the mfERGs
Fig. 2 shows the local 61 ERGs of a normal subject
(A) and of a BMD patient (D). Both subjects are rep-
resentative of the median results of the two populations
based upon the peak amplitude of the central response.
There is a substantial amplitude decrease for the central
element in this BMD patient, whereas the summed re-
sponses for rings 2–5 were not decreased (see amplitude
values in Fig. 2B and E). This can be also seen in the
three-dimensional plots of the ERG response density
(Fig. 2C and F).
To estimate a normal distribution we converted the
amplitudes into their logarithms. Eight of 18 BMD pa-
tients (44%) exhibited ERG response amplitudes for the
central response below the ﬁfth percentile of the normal
distribution estimated from the normal subjects, whereas
none of the ERG responses was above the 95th per-
centile. In ring 2, six BMD patients (33%) showed sub-
normal responses and no patient exhibited supernormal
responses. In the most eccentric elements (ring 5), only
one BMD patient exhibited an ERG amplitude below
the ﬁfth percentile, whereas three BMD patients showed
ERG responses above the 95th percentile. In Fig. 3, the
mfERG response amplitudes are shown for individual
patients. Patients of the same clinical stage according to
H.P.N. Scholl et al. / Vision Research 42 (2002) 1053–1061 1055
the classiﬁcation of Fishman are represented by the
same symbol. Again, abnormal mfERG response am-
plitudes are most frequent for ring 1, whereas there are
only minor abnormalities in more peripheral responses
(one reduced response amplitude in ring 5). There is a
considerable interindividual variability even between
patients of the same clinical stage. However, there is a
weak correlation between mfERG response amplitude
and clinical stage which could be statistically demon-
strated for the central response (see below).
The amplitude data of the normal subjects and the
BMD patients in rings 1–5 showed unequal variances
(Bartlett’s F-test; F ratio¼ 270; p < 0:0001). We there-
fore standardized the variances. To correct for the in-
Fig. 2. MfERGs recorded from the left eye of one normal subject (A; representing the median for the central element within the control population
of 55 subjects) and from the left eye of BMD patient #14 (D; representing the median for the peak amplitude of the central element within the
population of 18 BMD patients). The upper panels show the trace arrays with 61 focal ERGs (A, D). Patient #14 with a visual acuity of 1.0 shows a
markedly reduced central peak amplitude (0–2 eccentricity; D). In the more eccentric elements, the amplitudes are normal or even elevated. The
ERG responses of the ﬁve regional groups (response density scaled) are shown in the middle row for the normal subject (B) and the BMD patient (E).
Compared to the normal subject, the amplitudes are decreased for the central element, are normal for rings 2 and 3, and are near the 95th percentile
of the normal subjects for rings 4 and 5. The implicit times are within normal limits for every grouped ERG response. Additionally, three-
dimensional plots of the response density using the scalar product method are shown in the lower panels (C, F). The ERG response decrease for the
central element is evident by the absence of the sharp central peak (F).
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ﬂuence of age we applied an ANCOVA to the amplitude
data. We assumed that the variability in the data was
inﬂuenced by four factors—subject group (normal sub-
jects, BMD patients), rings (1–5), age, and subject
number as a random eﬀect—and that rings and subject
group could interact. The model ﬁt was good (R2 adj: ¼
0:74; residual S.D.¼ 0.51). ANCOVA revealed that the
amplitudes diﬀered signiﬁcantly between subject groups
(p < 0:0001) and between rings 1–5 (p < 0:0001). The
interaction of subject group and ERG amplitudes in
rings 1–5 was also signiﬁcant (p < 0:0001). Age inﬂu-
enced the amplitude data signiﬁcantly (p < 0:0001).
Post hoc t-tests (Bonferroni–Holm procedure for
multiple comparisons) revealed that the ERG ampli-
tudes for the central element and for rings 2 and 3 were
signiﬁcantly reduced in the BMD patients (p < 0:001),
whereas there was no signiﬁcant diﬀerence for the more
eccentric rings (Fig. 4A).
The ERG amplitude of the central response was sig-
niﬁcantly correlated with the visual acuity (r ¼ 0:54;
p ¼ 0:02) and with the staging according to the classi-
ﬁcation of Fishman (Kendall Tau b ¼ 0:37; p ¼ 0:05).
There was no signiﬁcant correlation with either the
age of onset (r ¼ 0:29; p ¼ 0:24), the disease duration
(r ¼ 0:32; p ¼ 0:2) or the EOG L/D ratio (r ¼ 0:37;
p ¼ 0:2).
Considering individual data, we found that one of the
eight patients with a visual acuity of 1.0 and better
(patient #2) exhibited an ERG amplitude of the central
response below the ﬁfth percentile of the normal sub-
jects, whereas this was the case for two of four BMD
patients with borderline visual acuity (0.8; patients #6
and #9). Interestingly, all ﬁve patients with a visual
acuity of 1.0 or better and fundus stages of three or four
(patients #1, #10, #14, #17, #18) exhibited central re-
sponse amplitudes that were within the normal limits,
although four of ﬁve were near the ﬁfth percentile of
the normal subjects. Four of ﬁve patients with a consid-
erably reduced visual acuity (0.2 and below) showed
subnormal central responses (patients #8, #13, #15,
#16).
Table 1
Clinical characteristics and photopic ERGs of the BMD patients who participated in the study
No. Age Sex VA Stage Photopic b-wave
Amplitude Implicit time
1 53 M 1.0 3 225.4 29.6
2 47 M 1.5 1 171.9 28.8
3 45 F 0.8 4 136.7 33.6
4 38 M 1.25 1 np np
5 45 M 0.8 2 125.1 27.6
6 34 F 0.8 3 194.9 28.4
7 21 F 0.6 4 149.0 28.2
8 9 M 0.2 4 np np
9 7 F 0.8 2 391.2 26.4
10 37 F 1.0 3 293.4 30.2
11 35 F 1.25 1 259.3 30.0
12 19 F 0.2 3 287.2 25.8
13 41 F 0.2 4 245.4 31.2
14 19 F 1.0 3 143.9 30.2
15 39 M 0.1 4 180.0 28.6
16 55 M 0.1 4 123.5 28.2
17 13 F 1.0 4 266.6 28.6
18 38 M 1.25 4 np np
Norma 97–223 27.7–32.2
Age (years), sex, visual acuity (VA) of the analyzed eye, and disease stage according to the classiﬁcation of Fishman et al. (1993) are listed. The last
two columns provide the photopic ERG b-wave amplitude (lV) and implicit time (ms). np: not performed.
aNormative values (ﬁfth and 95th percentiles).
Fig. 3. MfERG peak amplitudes (nV/deg2) are shown for individual
patients and for grouped responses of diﬀerent eccentricity (rings 1–5).
The peak amplitudes are not standardized as in Fig. 4. Patients of the
same clinical stage according to the classiﬁcation of Fishman are
represented by the same symbol. The normative values (ﬁfth and 95th
percentiles) are shown as gray boxes between horizontal marks.
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3.3. Implicit times of the mfERGs
The mean implicit times did not show large diﬀer-
ences between the two populations. There was consid-
erable overlap between the two subject groups for the
implicit times of every group of ERG responses. As for
the amplitude data, we converted the implicit times into
their logarithms to estimate a normal distribution. For
the central response, two of 18 BMD patients exhibited
prolonged implicit times above the 95th percentile of the
distribution of the normal subjects, whereas two BMD
patients showed ERG responses below the ﬁfth per-
centile. In the most eccentric elements (ring 5), however,
eight BMD patients exhibited prolonged implicit times
above the 95th percentile, whereas none of the ERG
responses was below the ﬁfth percentile.
The temporal data of the normal subjects and the
BMD patients in rings 1–5 showed unequal variances
(Bartlett’s F-test; F ratio¼ 29.3; p < 0:0001). We there-
fore standardized the variances. To correct for the in-
ﬂuence of age we applied an ANCOVA to the implicit
times. Again, we assumed that the variability in the data
was inﬂuenced by four factors—subject group (normal
subjects, BMD patients), rings (1–5), age, and subject
number as a random eﬀect—and that rings and subject
group could interact. The model ﬁt was excellent
(R2 adj: ¼ 0:96; residual S.D.¼ 0.56). ANCOVA re-
vealed that the implicit times between subject groups
(p < 0:0001) and between rings 1–5 (p < 0:0001) diﬀered
signiﬁcantly. The interaction of subject group and im-
plicit times in rings 1–5 was also signiﬁcant (p < 0:02).
Age inﬂuenced the implicit times signiﬁcantly (p <
0:0001).
Post hoc t-tests (Bonferroni–Holm procedure) re-
vealed that the implicit times for the rings 3 and 5 were
signiﬁcantly increased in the BMD patients (p < 0:01
and p < 0:001, respectively), whereas there was no sig-
niﬁcant increase for the other group responses (Fig. 4B).
3.4. Standard ERG
Photopic b-wave amplitude was either normal or
even super-normal in the BMD patients (range: 125–391
lV; mean: 213 lV; Table 1). Seven of 15 BMD patients
exhibited b-wave amplitudes above the 95th percentile
of the normal subjects (223 lV), whereas none was
below the ﬁfth percentile of the normal subjects (97 lV).
Mean photopic b-wave implicit time of the BMD pa-
tients was 29.0 ms (S.D.¼ 1.9 ms; range: 25.8–33.6 ms).
Three of 15 BMD patients showed b-wave implicit times
below the ﬁfth percentile of the normal subjects (27.7
ms), whereas the implicit time of one BMD patient
was above the 95th percentile of the normal subjects
(32.2 ms).
4. Discussion
The mfERG results of the present study reveal
functional deﬁcits of the neurosensory retina in BMD.
These alterations may be secondary to changes in the
RPE, since morphological and genetic studies have
suggested that the primary defect in BMD resides in the
RPE cells. On the basis of the present data, however,
primary or secondary dysfunctions cannot be distin-
guished.
The changes found in the mfERGs suggest speciﬁc
sites and mechanisms of retinal damage (for a review see
Hood, 2000). It has been hypothesized that damage to
the cone photoreceptor outer segments will reduce the
peak amplitude and result only in moderately (i.e.
<about 6 ms) increased implicit times; damage beyond
Fig. 4. Predicted values of peak amplitude (A) and implicit time (B)
obtained from the ANCOVA by back-transformation to the original
scale by eccentricity. 1 S.D. error bars are shown, as conﬁdence in-
tervals would fall within the markers. Asterisks indicate signiﬁcant
diﬀerences ( p < 0:001;  p < 0:01).
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the outer segments would imply at least moderate delays
(e.g. >about 4 ms) (Hood, 2000). Since we found a
considerable reduction of the peak amplitudes (mean of
14 nV/deg2 for the central element) with only slightly
increased implicit times (mean of only 0.4 ms for ring 5),
we suggest that these functional deﬁcits indicate either
cone photoreceptor cell loss or damage to the cone outer
segments.
The analysis of the present study was restricted on the
ﬁrst-order mfERG response kernel. Sutter and Tran
(1992) have shown that under photopic conditions the
ﬁrst-order response component can be well correlated to
cone density and outer retinal function. The mfERG
response may be a ‘‘little ERG’’ in the sense that it can
be broken into contributions from the same cellular
components as the full-ﬁeld ERG (Hood, 2000; Hood
et al., 1997). However, it is not a ‘‘little ERG’’ that is
simply modiﬁed by adapting conditions of the m-
sequence (Hood, 2000). These adaptive (non-linear)
processes of the retina are more reﬂected by the second-
order kernel, which appears to be inﬂuenced by the
adaptation to successive ﬂashes and to have substantial
contributions from sources in the inner retina and also
from the optic nerve head (Sutter, 2001; Sutter & Bearse,
1995). This second-order kernel response is undoubtedly
due to more than one non-linear process, but these
processes are not fully understood (Hood, 2000). Since
the VMD2 gene is mainly expressed in the RPE cells
suggesting outer retinal function impairment rather than
inner retinal damage and given that the physiological
background of the second-order mfERG responses is
still under discussion, it may be justiﬁed that we focused
on the ﬁrst-order component of the mfERG.
The amplitude decreases for the central ERG re-
sponse were signiﬁcantly correlated with visual acuity
loss. Seven BMD patients with a visual acuity of 0.8 (20/
25) or above exhibited peak amplitudes 1 S.D. below the
normal mean. In three of them (#2, #6, #9), the central
peak amplitude was below the ﬁfth percentile of the
normal subjects. This suggests that the mfERG can
serve as an early indicator of functional loss in BMD.
On the other hand, it was found that central retinal
function can be preserved when funduscopically there is
already resorption of the vitelliform lesion or even scar
formation visible.
As mentioned above, the implicit time increase was
only small when absolute values are taken into account.
It is known that the mfERG shows only little inter-
individual variability in normal subjects (Seeliger, Kret-
schmann, Apfelstedt, & Zrenner, 1998); this is also true
for the BMD patients. Since age inﬂuenced the data
signiﬁcantly, a correction for this parameter would re-
duce the interindividual variability even further. This
explains why the diﬀerences between the two subject
groups diﬀer signiﬁcantly for ring 3 and 5 although the
absolute diﬀerences are small. We do not ﬁnd the im-
plicit times useful for distinguishing BMD patients from
normal subjects in the clinical setting. However, it is
remarkable that we ﬁnd temporal alterations in grouped
ERG responses at a retinal eccentricity of 17–30 in
BMD patients whose funduscopic abnormalities were
conﬁned to a considerably more central area. But clin-
ically, these changes are of uncertain functional signiﬁ-
cance.
Other macular diseases have been investigated by
means of the mfERG and have shown speciﬁc patterns
of alterations that diﬀer from BMD. In Stargardt ma-
cular dystrophy (SMD), the ERG responses were re-
ported to be substantially decreased for the central
element; the amplitude reduction for the most eccentric
elements was only small but still signiﬁcant (Kretsch-
mann et al., 1998a). The implicit times were signiﬁcantly
prolonged for rings 2–5; however, as in the present study
with BMD patients the diﬀerences in implicit time were
small. Kretschmann, Seeliger, Ruether, Usui, and
Zrenner (1998b) also diﬀerentiated between early and
advanced SMD and found that in the majority of pa-
tients with early SMD, a foveal response could not be
recorded. This clearly diﬀers from BMD where we could
obtain a foveal response in every patient. In age-related
macular degeneration, signiﬁcant amplitude decreases
were found in rings 1–4 with increased implicit times for
rings 1–5 (Kretschmann et al., 1998a). The amplitude
decreases were comparable to early SMD. Patients with
cone dystrophy exhibit a diﬀerent pattern of results since
the ERG responses are strongly reduced or even non-
detectable in the entire ﬁeld of visual stimulation
(Kretschmann et al., 1998a). As a result, the mfERG can
contribute in the diﬀerential diagnosis of retinal diseases
aﬀecting the posterior pole of the retina.
The diagnosis of BMD was based on typical fundu-
scopic alterations and markedly reduced L/D ratios. A
subset of nine BMD patients, however, did not show a
positive family history with aﬀected members in at least
three consecutive generations. In a recent study, it was
reported that 85% of BMDpatients with a positive family
history show VMD2 sequence variations, whereas the
yield was signiﬁcantly lower (28%) for BMD patients
who were diagnosed clinically without a positive family
history (Lotery et al., 2000). Lotery et al. have suggested
that the latter are possibly aﬀected with a molecularly
diﬀerent disease that mimics BMD ophthalmoscopi-
cally. However, our study suggests that the subset of
patients without positive family history is aﬀected by
BMD: ﬁrst, all patients exhibited markedly reduced L/D
ratios in the EOG. EOGs were not obtained by Lotery
et al.; it is well-established that markedly reduced
L/D ratios are strongly indicative for BMD. Other ma-
cular diseases which also aﬀect the RPE such as age-
related macular degeneration (Lotery et al., 2000),
SMD (Hadden & Gass, 1976; Noble & Carr, 1979),
dominant drusen (Deutmann, 1971; Fishman, Carrasco,
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& Fishman, 1976; Gass, Jallow, & Davis, 1985), or pat-
tern dystrophy (Hsieh, Fine, & Lyons, 1977; Marmor &
Byers, 1977; Wakabayashi, Yonemura, & Kawasaki,
1983; Watzke, Folk, & Lang, 1982) usually exhibit
normal or only modestly subnormal EOGs. Secondly,
the patient group exhibited rather uniform functional
deﬁcits in the mfERG, taking into account that diﬀerent
stages of BMD were involved. Since the staging was
positively correlated with functional loss in the mfERG,
a correction for that would lead to a rather uniform
group suggesting that these patients are aﬀected by a
similar pathomechanism. Thirdly, the patient carrying a
mutation in the VMD2 gene showed a pattern of alter-
ations in the mfERG that was representative for the
whole patient study group. And fourthly, many exam-
ples of reduced penetrance and expressivity, and even
occasionally skipped generations, have been reported in
the literature (Krill, 1977). Moreover, it is known that
VMD2 gene mutations can be found in patients who are
clinically diagnosed as BMD but do not have a positive
family history (Palomba et al., 2000).
The mfERGs clearly demonstrate that topographi-
cally the retina is inhomogeneously aﬀected in BMD.
While the central elements (rings 1–3; corresponding to
0–13 eccentricity) exhibit amplitude decreases, the more
eccentric elements show completely normal amplitudes.
Simultaneously, 47% of the BMD patients exhibited
increased photopic b-waves above the normal 95%
percentile. This is in accordance with a previous study
where it was suggested that BMD is characterized by
increased large-ﬁeld ERG sensitivities when L- and M-
cone driven ERGs are taken into account (Scholl et al.,
2000). It is tempting to speculate that if more eccentric
local ERGs outside the central test ﬁeld were used they
would be increased in amplitude in the BMD patients as
a group. Possibly, these amplitude increases in the L-
and M-cone driven ERGs and in the photopic standard
ERG are due to ischemia or due to increased blood ﬂow
rates and/or pH changes within the retina that are
secondary eﬀects of hypoxia (Scholl et al., 2000). The
pathomechanism apparently has an inhomogeneous ef-
fect on the retina and presumably leads to permanent
functional defects in the macular region that are re-
ﬂected by the central amplitude decreases in the
mfERG.
Acknowledgements
We thank D.C. Hood, J. Kremers, and A. Kurten-
bach for their comments on the manuscript; B.H.F.
Weber for providing the data on the bestrophin muta-
tion; E. Apfelstedt-Sylla for clinical assistance; K.
Vohrer and J. Isensee for technical assistance; R. Hofer
for graphical assistance; M.W. Seeliger for general
support. This work was supported by fort€une-Grant
707-0-1 (T€ubingen, Germany) to HS.
References
Bakall, B., Marknell, T., Ingvast, S., Koisti, M. J., Sandgren, O.,
Li, W., Bergen, A. A., Andreasson, S., Rosenberg, T., Petrukhin,
K., & Wadelius, C. (1999). The mutation spectrum of the
bestrophin protein—functional implications. Human Genetics,
104, 383–389.
Curcio, C. A., Sloan, K. R., Kalina, R. E., & Hendrickson, A. E.
(1990). Human photoreceptor topography. Journal of Comparative
Neurology, 292, 497–523.
Denden, A. (1966). €Uber wenig bekannte multiple vitelliforme Reti-
nalzysten des hinteren Fundusabschnittes. Klinische Monatsbl€atter
f€ur Augenheilkunde, 149, 609–626.
Deutmann, A. F. (1971). The hereditary dystrophies of the posterior
pole of the eye. Assen, The Netherlands: Koninklijke Van Gorcum
& Comp NV.
Eksandh, L., Bakall, B., Bauer, B., Wadelius, C., & Andreasson, S.
(2001). Best’s vitelliform macular dystrophy caused by a new
mutation (Val89Ala) in the VMD2 gene. Ophthalmic Genetics, 22,
107–115.
Falsini, B., Porciatti, V., Porrello, G., Merendino, E., Minnella, A.,
Cermola, S., & Buzzonetti, L. (1996). Macular ﬂicker electroretino-
grams in Best vitelliform dystrophy. Current Eye Research, 15,
638–646.
Fishman, G. A., Baca, W., Alexander, K. R., Derlacki, D. J., Glenn,
A. M., & Viana, M. (1993). Visual acuity in patients with Best
vitelliform macular dystrophy. Ophthalmology, 100, 1665–1670.
Fishman, G. A., Carrasco, C., & Fishman, M. (1976). The electro-
oculogram in diﬀuse (familial) drusen. Archives of Ophthalmology,
94, 231–233.
Francois, J. (1968). Vitelliform degeneration of the macula. Bulletin of
the New York Academy of Medicine, 44, 18–27.
Frangieh, G. T., Green, W. R., & Fine, S. L. (1982). A histopathologic
study of Best’s macular dystrophy. Archives of Ophthalmology, 100,
1115–1121.
Gass, J. D., Jallow, S., & Davis, B. (1985). Adult vitelliform macular
detachment occurring in patients with basal laminar drusen.
American Journal of Ophthalmology, 99, 445–459.
Hadden, O. B., & Gass, J. D. (1976). Fundus ﬂavimaculatus and
Stargardt’s disease. American Journal of Ophthalmology, 82, 527–
539.
Hood, D. C. (2000). Assessing retinal function with the multifocal
technique. Progress in Retinal and Eye Research, 19, 607–646.
Hood, D. C., Seiple, W., Holopigian, K., & Greenstein, V. (1997). A
comparison of the components of the multifocal and full-ﬁeld
ERGs. Visual Neuroscience, 14, 533–544.
Hsieh, R. C., Fine, B. S., & Lyons, J. S. (1977). Patterned dystrophies
of the retinal pigment epithelium. Archives of Ophthalmology, 95,
429–435.
Kremers, J., Usui, T., Scholl, H. P. N., & Sharpe, L. T. (1999). Cone
signal contributions to electroretinograms in dichromats and
trichromats. Investigative Ophthalmology & Visual Science, 40,
920–930.
Kretschmann, U., Seeliger, M., Ruether, K., Usui, T., & Zrenner, E.
(1998a). Spatial cone activity distribution in diseases of the
posterior pole determined by multifocal electroretinography. Vision
Research, 38, 3817–3828.
Kretschmann, U., Seeliger, M. W., Ruether, K., Usui, T., Apfelstedt,
S. E., & Zrenner, E. (1998b). Multifocal electroretinography in
patients with Stargardt’s macular dystrophy. British Journal of
Ophthalmology, 82, 267–275.
1060 H.P.N. Scholl et al. / Vision Research 42 (2002) 1053–1061
Krill, A. E. (1977). Krill’s hereditary retinal and choroidal diseases (Vol.
II). Clinical characteristics. Hagerstown, MD: Harper and Row.
Krill, A. E., Morse, P. A., Potts, A. M., & Klien, B. A. (1966).
Hereditary vitelliruptive macular degeneration. American Journal
of Ophthalmology, 61, 1405–1415.
Lotery, A. J., Munier, F. L., Fishman, G. A., Weleber, R. G.,
Jacobson, S. G., Aﬀatigato, L. M., Nichols, B. E., Schorderet, D.
F., Sheﬃeld, V. C., & Stone, E. M. (2000). Allelic variation in the
VMD2 gene in Best disease and age-related macular degeneration.
Investigative Ophthalmology & Visual Science, 41, 1291–1296.
Marmor, M. F., & Byers, B. (1977). Pattern dystrophy of the pigment
epithelium. American Journal of Ophthalmology, 84, 32–44.
Marmor, M. F., & Zrenner, E. (1993). Standard for clinical electro-
oculography (International Society for Clinical Electrophysiology
of Vision). Archives of Ophthalmology, 111, 601–604.
Marmor, M. F., & Zrenner, E. (1998). Standard for clinical electro-
retinography (1999 update) (International Society for Clinical
Electrophysiology of Vision). Documenta Ophthalmologica, 97,
143–156.
Marquardt, A., Stohr, H., Passmore, L. A., Kramer, F., Rivera, A., &
Weber, B. H. (1998). Mutations in a novel gene, VMD2, encoding a
protein of unknown properties cause juvenile-onset vitelliform
macular dystrophy (Best’s disease). Human Molecular Genetics, 7,
1517–1525.
Noble, K. G., & Carr, R. E. (1979). Stargardt’s disease and fundus
ﬂavimaculatus. Archives of Ophthalmology, 97, 1281–1285.
O’Gorman, S., Flaherty, W. A., Fishman, G. A., & Berson, E. L.
(1988). Histopathologic ﬁndings in Best’s vitelliform macular
dystrophy. Archives of Ophthalmology, 106, 1261–1268.
Palomba, G., Rozzo, C., Angius, A., Pierrottet, C. O., Orzalesi, N., &
Pirastu, M. (2000). A novel spontaneous missense mutation in
VMD2 gene is a cause of a Best macular dystrophy sporadic case.
American Journal of Ophthalmology, 129, 260–262.
Petrukhin, K., Koisti, M. J., Bakall, B., Li, W., Xie, G., Marknell, T.,
Sandgren, O., Forsman, K., Holmgren, G., Andreasson, S., Vujic,
M., Bergen, A. A., McGarty, D. V., Figueroa, D., Austin, C. P.,
Metzker, M. L., Caskey, C. T., & Wadelius, C. (1998). Identiﬁca-
tion of the gene responsible for Best macular dystrophy. Nature
Genetics, 19, 241–247.
Scholl, H. P. N., & Kremers, J. (2000). Large phase diﬀerences between
L-cone and M-cone driven electroretinograms in retinitis pig-
mentosa. Investigative Ophthalmology & Visual Science, 41, 3225–
3233.
Scholl, H. P. N., Kremers, J., Apfelstedt-Sylla, E., & Zrenner, E.
(2000). L- and M-cone driven ERGs are diﬀerently altered in Best’s
macular dystrophy. Vision Research, 40, 3159–3168.
Seeliger, M. W., Kretschmann, U. H., Apfelstedt, S. E., & Zrenner, E.
(1998). Implicit time topography of multifocal electroretinograms.
Investigative Ophthalmology & Visual Science, 39, 718–723.
Sutter, E. E. (1991). The fast m-transform: a fast computation of cross-
correlations with binary m-sequences. SIAM Journal on Compu-
ting, 20, 686–694.
Sutter, E. E. (1992). A deterministic approach to nonlinear systems
analysis. In R. B. Pinter, & B. Nabet (Eds.), Nonlinear vision:
determination of neural receptive ﬁelds, function, and networks
(pp. 171–220). Boca Raton: CRC Press.
Sutter, E. E. (2001). Imaging visual function with the multifocal
m-sequence technique. Vision Research, 41, 1241–1255.
Sutter, E. E., & Bearse, M. A. (1995). Extraction of a ganglion cell
component from the corneal response. In 1995 OSA technical digest
series (Vol. 1). Vision science and its applications (pp. 310–313).
Washington, DC: Optical Society of America.
Sutter, E. E., & Tran, D. (1992). The ﬁeld topography of ERG
components in man—I. The photopic luminance response. Vision
Research, 32, 433–446.
Wakabayashi, K., Yonemura, D., & Kawasaki, K. (1983). Electro-
physiological analysis of Best’s macular dystrophy and retinal
pigment epithelial pattern dystrophy. Ophthalmic Paediatrics and
Genetics, 3, 13–17.
Watzke, R. C., Folk, J. C., & Lang, R. M. (1982). Pattern dystrophy of
the retinal pigment epithelium. Ophthalmology, 89, 1400–1406.
Weingeist, T. A., Kobrin, J. L., & Watzke, R. C. (1982). Histopatho-
logy of Best’s macular dystrophy. Archives of Ophthalmology, 100,
1108–1114.
H.P.N. Scholl et al. / Vision Research 42 (2002) 1053–1061 1061
